| Primary |
| Hypertension |
56.5% |
| Product Used For Unknown Indication |
19.6% |
| Blood Cholesterol Increased |
4.3% |
| Blood Pressure |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Heart Rate Increased |
2.2% |
| Heart Rate Irregular |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Hyperthyroidism |
2.2% |
| Pain |
2.2% |
| Sleep Disorder |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
|
| Heart Rate Irregular |
8.3% |
| Myocardial Infarction |
8.3% |
| Road Traffic Accident |
8.3% |
| Thirst |
8.3% |
| Abdominal Pain |
4.2% |
| Alopecia |
4.2% |
| Atrioventricular Block First Degree |
4.2% |
| Blindness Unilateral |
4.2% |
| Blood Pressure Inadequately Controlled |
4.2% |
| Cerebrovascular Accident |
4.2% |
| Confusional State |
4.2% |
| Death |
4.2% |
| Dehydration |
4.2% |
| Drug Effect Increased |
4.2% |
| Dysphemia |
4.2% |
| Eating Disorder |
4.2% |
| Eye Disorder |
4.2% |
| Lung Neoplasm Malignant |
4.2% |
| Neoplasm Malignant |
4.2% |
| Nephropathy |
4.2% |
|
| Secondary |
| Hypertension |
66.7% |
| Blood Cholesterol Increased |
11.1% |
| Influenza Immunisation |
7.4% |
| Bile Acid Malabsorption |
3.7% |
| Blood Testosterone Decreased |
3.7% |
| Erectile Dysfunction |
3.7% |
| Product Used For Unknown Indication |
3.7% |
|
| Myocardial Infarction |
18.2% |
| Oedema Peripheral |
18.2% |
| Adrenal Insufficiency |
9.1% |
| Blood Testosterone Decreased |
9.1% |
| Eye Swelling |
9.1% |
| Muscle Spasms |
9.1% |
| Post Procedural Complication |
9.1% |
| Renal Cancer |
9.1% |
| Tinnitus |
9.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
49.4% |
| Hypertension |
9.9% |
| Diabetes Mellitus |
5.1% |
| Blood Cholesterol Increased |
3.4% |
| Glaucoma |
3.2% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Asthma |
2.8% |
| Psoriasis |
2.6% |
| Rheumatoid Arthritis |
2.4% |
| Atrial Fibrillation |
2.2% |
| Blood Pressure |
2.2% |
| Insomnia |
2.0% |
| Pain |
2.0% |
| Arthralgia |
1.6% |
| Depression |
1.6% |
| High Density Lipoprotein Decreased |
1.6% |
| Blood Cholesterol |
1.4% |
| Blood Pressure Abnormal |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Blood Triglycerides Increased |
1.2% |
|
| Flushing |
11.8% |
| Blood Pressure Increased |
5.9% |
| Drug Ineffective |
5.9% |
| Joint Swelling |
5.9% |
| Off Label Use |
5.9% |
| Pruritus |
5.9% |
| Restless Legs Syndrome |
5.9% |
| Visual Acuity Reduced |
5.9% |
| Blood Glucose Increased |
3.9% |
| Cough |
3.9% |
| Cyclic Vomiting Syndrome |
3.9% |
| Gastrointestinal Haemorrhage |
3.9% |
| Hyperhidrosis |
3.9% |
| Impaired Healing |
3.9% |
| Injection Site Pain |
3.9% |
| Oropharyngeal Blistering |
3.9% |
| Rash |
3.9% |
| Rash Macular |
3.9% |
| Rash Papular |
3.9% |
| Skin Ulcer |
3.9% |
|
| Interacting |
| Blood Cholesterol Increased |
100.0% |
|
|
